Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth
Leuk Res
.
1996 Apr;20(4):303-7.
doi: 10.1016/0145-2126(95)00085-2.
Authors
A Ogata
1
,
K C Anderson
Affiliation
1
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
PMID:
8642841
DOI:
10.1016/0145-2126(95)00085-2
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review
MeSH terms
Cell Division / drug effects
Humans
Interleukin-6 / pharmacology*
Multiple Myeloma / pathology*
Tumor Cells, Cultured
Substances
Interleukin-6
Grants and funding
CA 50947/CA/NCI NIH HHS/United States